- Home
- SQNS vs ATRA Comparison
SQNS vs ATRA Comparison
Compare SQNS & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- ATRA
- Stock Information
- Founded
- SQNS 2003
- ATRA 2012
- Country
- SQNS France
- ATRA United States
- Employees
- SQNS N/A
- ATRA N/A
- Industry
- SQNS Semiconductors
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SQNS Technology
- ATRA Health Care
- Exchange
- SQNS Nasdaq
- ATRA Nasdaq
- Market Cap
- SQNS 113.4M
- ATRA 97.0M
- IPO Year
- SQNS 2011
- ATRA 2014
- Fundamental
- Price
- SQNS $5.94
- ATRA $11.42
- Analyst Decision
- SQNS Strong Buy
- ATRA Strong Buy
- Analyst Count
- SQNS 2
- ATRA 3
- Target Price
- SQNS $24.00
- ATRA $21.00
- AVG Volume (30 Days)
- SQNS 377.3K
- ATRA 56.3K
- Earning Date
- SQNS 11-04-2025
- ATRA 11-06-2025
- Dividend Yield
- SQNS N/A
- ATRA N/A
- EPS Growth
- SQNS N/A
- ATRA N/A
- EPS
- SQNS N/A
- ATRA 0.56
- Revenue
- SQNS $31,534,000.00
- ATRA $188,667,000.00
- Revenue This Year
- SQNS N/A
- ATRA N/A
- Revenue Next Year
- SQNS $57.61
- ATRA N/A
- P/E Ratio
- SQNS N/A
- ATRA $19.09
- Revenue Growth
- SQNS 3.20
- ATRA 202.41
- 52 Week Low
- SQNS $5.83
- ATRA $5.01
- 52 Week High
- SQNS $58.30
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- SQNS 34.56
- ATRA 37.12
- Support Level
- SQNS $5.83
- ATRA $10.50
- Resistance Level
- SQNS $8.17
- ATRA $15.30
- Average True Range (ATR)
- SQNS 0.64
- ATRA 1.26
- MACD
- SQNS -0.29
- ATRA -0.52
- Stochastic Oscillator
- SQNS 4.55
- ATRA 16.28
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).